Zhai et al. (2018) recently reported that the intraperitoneal administration of MCC950 (10 mg/kg) could downregulate the hippocampal NLRP3, ASC, and IL-1β expression levels and ameliorate cognitive impairment in diabetic db/db mice. This evidence concerns the gene IL1B and Cognitive impairment.